What type of information should be gathered by a pharmacy when dispensing controlled substances according to CMEA?

The reasoning behind gathering information about the product name, quantity, name and address of the purchaser, and the date and time when dispensing controlled substances relates to the regulations established by the Combat Methamphetamine Epidemic Act (CMEA). The CMEA was enacted to combat the illegal production and distribution of methamphetamine, which is often manufactured using certain controlled substances.

This legislation requires pharmacies to maintain a detailed log for every sale of regulated products. The information collected serves several purposes: it helps track the distribution patterns of substances that can potentially be misused, assists in preventing illegal distributions, and ensures accountability within pharmacies. By collecting the purchaser's name and address, along with the details of the product and its quantity, the pharmacy can provide sufficient records that can be reviewed by regulatory authorities if necessary.

In contrast, the other options do not align with the specific stipulations of the CMEA. For instance, while prescription details might seem relevant, they do not include the specific monitoring aspects required by the CMEA for pseudoephedrine or other regulated substances. Likewise, patient weight and height, or a doctor's specialty and practice details, are not typically required for the purposes of tracking sales under the CMEA, as these factors do not directly relate to preventing the diversion of